7CAB

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody

7CAB の概要

• エントリーDOI: 10.2210/pdb7cab/pdb
• EMDBエントリー: 30325
• 分子名称: Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total)
• 機能のキーワード: sars-cov-2, spike glycoprotein, viral protein
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
• タンパク質・核酸の鎖数: 3
• 化学式量合計: 414838.80

構造登録者

Zhe, L.,Cao, L.,Deng, Y.,Sun, Y.,Wang, N.,Xie, L.,Wang, Y.,Rao, Z.,Qin, C.,Wang, X. (登録日: 2020-06-08, 公開日: 2020-12-16, 最終更新日: 2021-03-10)

• 主引用文献: Lv, Z.,Deng, Y.Q.,Ye, Q.,Cao, L.,Sun, C.Y.,Fan, C.,Huang, W.,Sun, S.,Sun, Y.,Zhu, L.,Chen, Q.,Wang, N.,Nie, J.,Cui, Z.,Zhu, D.,Shaw, N.,Li, X.F.,Li, Q.,Xie, L.,Wang, Y.,Rao, Z.,Qin, C.F.,Wang, X.; Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody.; Science, 369:1505-1509, 2020; PubMed: 32703908; DOI: 10.1126/science.abc5881

実験手法

ELECTRON MICROSCOPY (3.52 Å)